A novel inhibitor of tumor necrosis factor-α converting enzyme ameliorates polycystic kidney disease
- 1 October 2001
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 60 (4), 1240-1248
- https://doi.org/10.1046/j.1523-1755.2001.00963.x
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (P50DK-57306)
- National Institutes of Health
This publication has 23 references indexed in Scilit:
- Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human KeratinocytesPublished by Elsevier BV ,2000
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- In vitro modulation of cyst formation by a novel tyrosine kinase inhibitorKidney International, 1999
- EGF receptorThe International Journal of Biochemistry & Cell Biology, 1999
- New insights into the molecular pathophysiology of polycystic kidney diseaseKidney International, 1999
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.JCI Insight, 1998
- Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubulesKidney International, 1996
- Epidermal growth factor receptor expression is abnormal in murine polycystic kidneyKidney International, 1995
- Characterization of high molecular weight transforming growth factor .alpha. produced by rat hepatocellular carcinoma cellsBiochemistry, 1988